Acute Intermittent Porphyria Market: Exploring the Role of Genetics...

added blog Health

2025-01-20 10:51:34 -

Acute Intermittent Porphyria Market: Exploring the Role of Genetics and Treatment Advancements

Acute Intermittent Porphyria (AIP) is a rare autosomal dominant metabolic disorder caused by a deficient activity of the enzyme porphobilinogen deaminase (PBGD). The disease is characterized by acute attacks of abdominal pain, vomiting, and neurological manifestations like paralysis and mental issues. The diagnosis of AIP can be confirmed through elevated urinary levels of porphobilinogen...

0 Comments 0 Shares 87 Views 0 Reviews